NYU LangoneNew York, New York, United States
I do not have any relevant financial / non-financial relationships with any proprietary interests.
19 - The Impact of Investigational Purified Microbiome Therapeutic SER-109 on Health-Related Quality of Life (HRQoL) of Patients with Recurrent Clostridioides difficile Infection (rCDI) in ECOSPOR III, a Placebo-Controlled Clinical Trial
On Demand